Author: Natoni Alessandro Coyne Mark R. E. Jacobsen Alan Rainey Michael D. O’Brien Gemma Healy Sandra Montagnoli Alessia Moll Jürgen O’Dwyer Michael Santocanale Corrado
Publisher: MDPI
E-ISSN: 2072-6694|5|3|901-918
ISSN: 2072-6694
Source: Cancers, Vol.5, Iss.3, 2013-07, pp. : 901-918
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Role of Immunotherapy in Multiple Myeloma
By Kocoglu Mehmet Badros Ashraf
Pharmaceuticals, Vol. 9, Iss. 1, 2016-01 ,pp. :
By Sun Ningning Sun Wanchun Li Shuiming Yang Jingbo Yang Longfei Quan Guihua Gao Xiang Wang Zijian Cheng Xin Li Zehui Peng Qisheng Liu Ning
International Journal of Molecular Sciences, Vol. 16, Iss. 11, 2015-10 ,pp. :
Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. :
Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
By Merin Noah M. Kelly Kevin R.
Pharmaceuticals, Vol. 8, Iss. 1, 2014-12 ,pp. :